Product Information
PROPYLTHIOURACIL 50 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2687 per EA under NDC 00480924201. Its NADAC has been published 110 times since Aug 28, 2024.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is BD.
Strength
50 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480924201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PROPYLTHIOURACILApproval Type
Generic (ANDA)
FDA Application
ANDA080172FDA Approved
Before 1982
TE Code
BD
On Market Since
7/10/2024
Pharmacological Classes
Price Statistics
The NADAC for PROPYLTHIOURACIL 50 MG TABLET has been published 110 times since Aug 28, 2024, and over the history we have for it it has risen 9.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2687 per EA |
|---|---|
| All-time high | $0.3341 (Jul 16, 2025) |
| All-time low | $0.2433 (Nov 20, 2024) |
| 52-week high | $0.3044 |
| 52-week low | $0.2646 |
| Median price | $0.2814 |
| Average price | $0.2875 |
| Largest weekly change | +25.4% (Sep 18, 2024) |
| Weeks tracked | 110 |
| Tracking since | Aug 28, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Propylthiouracil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Thyroid Hormone Synthesis Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROPYLTHIOURACIL 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PROPYLTHIOURACIL 50 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.2687 per EA (NDC 00480924201), effective Sep 30, 2026.
How has the price of PROPYLTHIOURACIL 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for PROPYLTHIOURACIL 50 MG TABLET has risen 9.9%. It has been tracked across 110 weekly CMS publications since Aug 28, 2024.
What are the highest and lowest recorded NADAC prices for PROPYLTHIOURACIL 50 MG TABLET?
Since Aug 28, 2024, the NADAC for PROPYLTHIOURACIL 50 MG TABLET has ranged from a low of $0.2433 (Nov 20, 2024) to a high of $0.3341 (Jul 16, 2025), with a median of $0.2814 per EA.
Are there cheaper alternatives to PROPYLTHIOURACIL 50 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PROPYLTHIOURACIL 50 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PROPYLTHIOURACIL 50 MG TABLET?
PROPYLTHIOURACIL 50 MG TABLET (NDC 00480924201) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.